Torrid Holdings Inc. (CURV) has staged one of the more dramatic small-cap retail rebounds of 2026. The plus-size women's apparel retailer fell as low as $0.94 in December 2025, then surged to a 52-week high of $2.86 in late July 2026 before pulling back to $2.20 at the latest close. The round-number $3.00 level now sits about 36% above the latest price and just above that July peak, making "Can CURV reach $3?" a natural question for traders and investors.
Round-number price levels often act as psychological magnets. For CURV, $3 would represent a decisive break above the July high and would confirm the 2026 uptrend with a higher high. It would also mark a full triple from the December low. However, the stock's slide of roughly 15% in the five sessions after touching $2.86 shows how quickly momentum can fade in a micro-cap name with a small public float.
Torrid is a specialty retailer focused on sizes 10 to 30, selling apparel, intimates, footwear, and accessories through stores and e-commerce under the Torrid, Torrid Curve, CURV, and Lovesick brands. The company generated about $980 million in trailing revenue, but sales have been shrinking: fiscal 2025 revenue fell 9.4% to roughly $1.0 billion, and trailing net income is slightly negative. With a market capitalization near $219 million and a price-to-sales ratio around 0.22, the stock trades as a deep-value, high-risk turnaround.
The most recent quarter offered early signs of stabilization. Torrid reported first-quarter fiscal 2026 sales of about $245.8 million, ahead of consensus, while adjusted EBITDA hit the high end of guidance and comparable sales excluding footwear turned positive. Management reaffirmed full-year adjusted EBITDA guidance of roughly $70 million at the midpoint and expects a footwear assortment reset to support the second half. Cost actions and store closures have also reshaped the business: Torrid closed 151 stores in 2025, e-commerce reached 64% of sales, and its loyalty program captures about 97% of sales. Sourcing diversification has reduced exposure to China. Finally, with short interest around 11.5% of the float, positive news could trigger sharp short-covering moves, a key ingredient for any push toward $3.
The counterargument is that Torrid has not yet proven it can grow again. Revenue has declined for six consecutive quarters on a year-over-year basis, and the latest quarter was still down about 7.6%. Trailing EPS is negative, and gross margin compressed by roughly 280 basis points in the first quarter because of tariffs and footwear clearance. The balance sheet also limits the margin for error: enterprise value is well above market capitalization, and reported liquidity metrics are thin. Beyond company-specific issues, analysts have highlighted GLP-1 weight-loss drug adoption as a structural risk to plus-size apparel demand, while Target, Walmart, and Old Navy continue to expand their own size-inclusive assortments.
Wall Street currently prices CURV for downside, not a breakout. Published 12-month targets range from about $0.75 to roughly $2.25, with the consensus near $1.60–$1.70, below the latest quote. Morgan Stanley resumed coverage with an Equalweight rating and a $1.80 target, Telsey Advisory has maintained a $2.00 Market Perform view, BofA Securities holds a Buy with a $2.00 target, and Goldman Sachs carries a Sell with a $0.75 target. Even the most bullish published targets sit below $3, so reaching that level would require fundamentals to improve enough to force a wholesale reset of analyst expectations.
From a technical analysis standpoint, $2.86 is the immediate supply zone; any credible run at $3 must first clear that July high. On the downside, the $2.00–$2.20 area is the first major support band, followed by $1.80, which aligns with Morgan Stanley's target and the stock's June consolidation zone. A break below $1.80 would weaken the 2026 recovery narrative and push $3 further out of reach.
For the $3 price target to become realistic, Torrid would likely need to string together several developments: a return to positive comparable sales in the second half of fiscal 2026, gross-margin recovery as the footwear reset matures, continued adjusted EBITDA expansion, and clearer evidence that the store fleet is stabilizing. Equally important, the market would need to see upward estimate revisions, because a stock cannot sustainably trade far above consensus targets without analysts raising their outlook. A stronger consumer spending backdrop and a manageable tariff environment would help, but the primary driver would have to be company-specific execution.
For traders monitoring CURV's fast-moving price action, Tickeron's AI Daily Buy/Sell Signals can complement independent research. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. In a volatile micro-cap name where sentiment can shift quickly around earnings and guidance, systematic AI monitoring may help traders discover opportunities, track existing positions, and identify changing trends more efficiently. Explore the signals to see how the current setup compares with your own market outlook.
Reaching $3.00 is not the base case for CURV, but it is not impossible. The bullish path rests on a genuine sales inflection, gross-margin repair, and short-covering momentum; the bearish path rests on persistent revenue declines, a leveraged balance sheet, and Wall Street targets that currently sit below the market price. Investors should monitor comparable sales, footwear performance, margin trends, and the next quarterly report due in early September 2026, as well as how the stock behaves around the $2.86 high. Until estimates begin moving higher, $3 remains an aspirational target rather than a likely near-term destination.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CURV has been loosely correlated with DBI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CURV jumps, then DBI could also see price increases.
| Ticker / NAME | Correlation To CURV | 1D Price Change % | ||
|---|---|---|---|---|
| CURV | 100% | -1.76% | ||
| DBI - CURV | 39% Loosely correlated | -1.90% | ||
| LULU - CURV | 35% Loosely correlated | +1.42% | ||
| GCO - CURV | 30% Poorly correlated | +2.74% | ||
| SHOE - CURV | 28% Poorly correlated | +1.19% | ||
| GAP - CURV | 27% Poorly correlated | +1.18% | ||
More | ||||